Advertisement

Der Chirurg

, Volume 90, Issue 2, pp 94–101 | Cite as

Weichgewebssarkome: Extremitätenerhalt durch plastisch-rekonstruktive Verfahren

  • M. LehnhardtEmail author
  • A. Sogorski
  • C. Wallner
  • M. Wagner
  • M. Dadras
  • B. Behr
  • K Harati
Leitthema
  • 62 Downloads

Zusammenfassung

Die Therapie der Wahl bei Weichteilsarkomen mit lokalisiertem Befall besteht weiterhin in der kompletten chirurgischen Entfernung im Gesunden. Das Ziel der operativen Therapie ist die Erlangung tumorfreier Resektionsränder im Sinne einer R0-Resektion. Keine andere Therapiemöglichkeit kann diese wichtige onkologische Kondition ebenbürtig ersetzen. Die enorme Entwicklung im Bereich der rekonstruktiven plastischen Chirurgie und hier insbesondere die Fortschritte in der Lappentechnik und Mikrochirurgie erlauben den Extremitätenerhalt und die funktionelle Rekonstruktion auch bei ausgedehnten Fällen.

Schlüsselwörter

Funktionelle Rekonstruktion Lappentechnik Amputation Chemotherapie Extremitätenpersfusion 

Soft tissue sarcomas: limb salvage using reconstructive plastic surgery techniques

Abstract

The treatment of choice for soft tissue sarcomas with local involvement is still the complete surgical removal into healthy tissue. The aim of surgery is to achieve tumor-free resection margins in the sense of a R0 resection. No other treatment option can equally replace this important oncological condition. The enormous development in the field of reconstructive plastic surgery and in particular the advances in flap techniques and microsurgery enable limb salvage and the functional reconstruction even in the case of extensive tumors.

Keywords

Functional reconstruction Surgical flaps Amputation Chemotherapy Limb perfusion 

Notes

Einhaltung ethischer Richtlinien

Interessenkonflikt

M. Lehnhardt, A. Sogorski, C. Wallner, M. Wagner, M. Dadras, B. Behr und K. Harati geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren. Für Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, über die Patienten zu identifizieren sind, liegt von ihnen und/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.

Literatur

  1. 1.
    Ahmad R, Jacobson A, Hornicek F et al (2016) The width of the surgical margin does not influence outcomes in extremity and truncal soft tissue sarcoma treated with radiotherapy. Oncologist 21:1269.  https://doi.org/10.1634/theoncologist.2015-0534 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Al-Absi E, Farrokhyar F, Sharma R et al (2010) A systematic review and meta-analysis of oncologic outcomes of pre- versus postoperative radiation in localized resectable soft-tissue sarcoma. Ann Surg Oncol 17:1367–1374CrossRefGoogle Scholar
  3. 3.
    Anonymous (1997) Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet 350:1647–1654CrossRefGoogle Scholar
  4. 4.
    Anonymous (2014) Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):iii102–iii112CrossRefGoogle Scholar
  5. 5.
    Beane JD, Yang JC, White D et al (2014) Efficacy of adjuvant radiation therapy in the treatment of soft tissue sarcoma of the extremity: 20-year follow-up of a randomized prospective trial. Ann Surg Oncol 21:2484–2489CrossRefGoogle Scholar
  6. 6.
    Behranwala KA, A’hern R, Omar AM et al (2004) Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol 11:714–719CrossRefGoogle Scholar
  7. 7.
    Billingsley KG, Burt ME, Jara E et al (1999) Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg 229:602–610 (discussion 610–602)CrossRefGoogle Scholar
  8. 8.
    Bonvalot S, Levy A, Terrier P et al (2016) Primary extremity soft tissue sarcomas: does local control impact survival? Ann Surg Oncol 24(1):194.  https://doi.org/10.1245/s10434-016-5462-2 CrossRefPubMedGoogle Scholar
  9. 9.
    Cannon CP, Ballo MT, Zagars GK et al (2006) Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer 107:2455–2461CrossRefGoogle Scholar
  10. 10.
    Coindre JM, Terrier P, Guillou L et al (2001) Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 91:1914–1926CrossRefGoogle Scholar
  11. 11.
    Demetri GD, Von Mehren M, Jones RL et al (2016) Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a phase III randomized multicenter clinical trial. J Clin Oncol 34:786–793CrossRefGoogle Scholar
  12. 12.
    Enneking WF, Spanier SS, Malawer MM (1981) The effect of the anatomic setting on the results of surgical procedures for soft parts sarcoma of the thigh. Cancer 47:1005–1022CrossRefGoogle Scholar
  13. 13.
    Fischer S, Soimaru S, Hirsch T et al (2015) Local tendon transfer for knee extensor mechanism reconstruction after soft tissue sarcoma resection. J Plast Reconstr Aesthet Surg 68:729–735CrossRefGoogle Scholar
  14. 14.
    Fletcher CD (2014) The evolving classification of soft tissue tumours – an update based on the new 2013 WHO classification. Histopathology 64:2–11CrossRefGoogle Scholar
  15. 15.
    Frassica FJ, Khanna JA, Mccarthy EF (2000) The role of MR imaging in soft tissue tumor evaluation: perspective of the orthopedic oncologist and musculoskeletal pathologist. Magn Reson Imaging Clin N Am 8:915–927PubMedGoogle Scholar
  16. 16.
    Gould DJ, Mehrara BJ, Neligan P et al (2018) Lymph node transplantation for the treatment of lymphedema. J Surg Oncol 118:736–742CrossRefGoogle Scholar
  17. 17.
    Grabellus F, Stylianou E, Umutlu L et al (2012) Size-based clinical response evaluation is insufficient to assess clinical response of sarcomas treated with isolated limb perfusion with TNF-alpha and melphalan. Ann Surg Oncol 19:3375–3385CrossRefGoogle Scholar
  18. 18.
    Grimer R, Judson I, Peake D et al (2010) Guidelines for the management of soft tissue sarcomas. Sarcoma 2010:1–15.  https://doi.org/10.1155/2010/506182 CrossRefGoogle Scholar
  19. 19.
    Gronchi A, Lo Vullo S, Colombo C et al (2010) Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survival. Ann Surg 251:506–511CrossRefGoogle Scholar
  20. 20.
    Harati K, Goertz O, Pieper A et al (2017) Soft tissue sarcomas of the extremities: surgical margins can be close as long as the resected tumor has no ink on it. Oncologist 22(11):1400.  https://doi.org/10.1634/theoncologist.2016-0498 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Harati K, Kirchhoff P, Behr B et al (2016) Soft tissue sarcomas of the distal lower extremities: a single-institutional analysis of the prognostic significance of surgical margins in 120 patients. Oncol Rep 36:863–870CrossRefGoogle Scholar
  22. 22.
    Harati K, Lehnhardt M (2017) The changing paradigm of resection margins in sarcoma resection. Innov Surg Sci:165.  https://doi.org/10.1515/iss-2017-0043 CrossRefGoogle Scholar
  23. 23.
    Hoda SA (2014) Enzinger and Weiss’s Soft Tissue Tumors, 6th Edition. Adv Anat Pathol 21:216CrossRefGoogle Scholar
  24. 24.
    Issels RD, Lindner LH, Verweij J et al (2018) Effect of neoadjuvant chemotherapy plus regional Hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: the EORTC 62961-ESHO 95 randomized clinical trial. JAMA Oncol 4:483–492CrossRefGoogle Scholar
  25. 25.
    Issels RD, Lindner LH, Verweij J et al (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11:561–570CrossRefGoogle Scholar
  26. 26.
    Judson I, Verweij J, Gelderblom H et al (2014) Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. Lancet Oncol 15:415–423CrossRefGoogle Scholar
  27. 27.
    Lehnhardt M, Daigeler A, Hauser J et al (2008) The value of expert second opinion in diagnosis of soft tissue sarcomas. J Surg Oncol 97:40–43CrossRefGoogle Scholar
  28. 28.
    Lehnhardt M, Harati K, Goertz O et al (2014) Möglichkeiten der plastischen Chirurgie in der Behandlung von Weichteilsarkomen. Onkologe 20:1103–1112CrossRefGoogle Scholar
  29. 29.
    Mardonado AA, Chen R, Chang DW (2017) The use of supraclavicular free flap with vascularized lymph node transfer for treatment of lymphedema: a prospective study of 100 consecutive cases. J Surg Oncol 115:68–71CrossRefGoogle Scholar
  30. 30.
    Mastrangelo G, Coindre JM, Ducimetiere F et al (2012) Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer 118:5339–5348CrossRefGoogle Scholar
  31. 31.
    Mckee MD, Liu DF, Brooks JJ et al (2004) The prognostic significance of margin width for extremity and trunk sarcoma. J Surg Oncol 85:68–76CrossRefGoogle Scholar
  32. 32.
    Mendenhall WM, Indelicato DJ, Scarborough MT et al (2009) The management of adult soft tissue sarcomas. Am J Clin Oncol 32:436–442CrossRefGoogle Scholar
  33. 33.
    Neuwirth MG, Song Y, Sinnamon AJ et al (2017) Isolated limb perfusion and infusion for extremity soft tissue sarcoma: a contemporary systematic review and meta-analysis. Ann Surg Oncol 24:3803–3810CrossRefGoogle Scholar
  34. 34.
    Noebauer-Huhmann IM, Weber MA, Lalam RK et al (2015) Soft tissue tumors in adults: ESSR-approved guidelines for diagnostic imaging. Semin Musculoskelet Radiol 19:475–482CrossRefGoogle Scholar
  35. 35.
    O’sullivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359:2235–2241CrossRefGoogle Scholar
  36. 36.
    Podleska LE, Kaya N, Farzaliyev F et al (2017) Lower limb function and quality of life after ILP for soft-tissue sarcoma. World J Surg Oncol 15:84CrossRefGoogle Scholar
  37. 37.
    Rath FW, Schönfelder M (2002) Weichteilsarkome des Erwachsenen: Standards, Molekularbiologie, Perspektiven. Karger, Freiburg im BreisgauCrossRefGoogle Scholar
  38. 38.
    Riad S, Griffin AM, Liberman B et al (2004) Lymph node metastasis in soft tissue sarcoma in an extremity. Clin Orthop Relat Res 426:129–134CrossRefGoogle Scholar
  39. 39.
    Sampath S, Schultheiss TE, Hitchcock YJ et al (2011) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma: multi-institutional analysis of 821 patients. Int J Radiat Oncol Biol Phys 81:498–505CrossRefGoogle Scholar
  40. 40.
    Schoffski P, Chawla S, Maki RG et al (2016) Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial. Lancet 387:1629–1637CrossRefGoogle Scholar
  41. 41.
    Steinau HU, Homann HH, Drucke D et al (2001) Resection method and functional restoration in soft tissue sarcomas of the extremities. Chirurg 72:501–513CrossRefGoogle Scholar
  42. 42.
    Steinau HU, Steinstrasser L, Hauser J et al (2012) Soft tissue sarcoma : resection and plastic reconstruction. Chirurg 83:673–684CrossRefGoogle Scholar
  43. 43.
    Steinau HU, Tofaute A, Huellmann K et al (2011) Tendon transfers for drop foot correction: long-term results including quality of life assessment, and dynamometric and pedobarographic measurements. Arch Orthop Trauma Surg 131:903–910CrossRefGoogle Scholar
  44. 44.
    Toro JR, Travis LB, Wu HJ et al (2006) Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: an analysis of 26,758 cases. Int J Cancer 119:2922–2930CrossRefGoogle Scholar
  45. 45.
    Tseng JF, Ballo MT, Langstein HN et al (2006) The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol 13:1209–1215CrossRefGoogle Scholar
  46. 46.
    Van Der Graaf WT, Blay JY, Chawla SP et al (2012) Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 379:1879–1886CrossRefGoogle Scholar
  47. 47.
    Von Mehren M, Randall RL, Benjamin RS et al (2016) Soft tissue sarcoma, version 2.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 14:758–786CrossRefGoogle Scholar
  48. 48.
    Wang D, Zhang Q, Eisenberg BL et al (2015) Significant reduction of late toxicities in patients with extremity sarcoma treated with image-guided radiation therapy to a reduced target volume: results of radiation therapy oncology group RTOG-0630 trial. J Clin Oncol 33:2231–2238CrossRefGoogle Scholar
  49. 49.
    Weichman KE, Dec W, Morris CD et al (2015) Lower extremity osseous oncologic reconstruction with composite microsurgical free fibula inside massive bony allograft. Plast Reconstr Surg 136:396–403CrossRefGoogle Scholar
  50. 50.
    Wibmer C, Leithner A, Zielonke N et al (2010) Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review. Ann Oncol 21:1106–1111CrossRefGoogle Scholar
  51. 51.
    Woll PJ, Reichardt P, Le Cesne A et al (2012) Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol 13:1045–1054CrossRefGoogle Scholar
  52. 52.
    Zagars GK, Ballo MT, Pisters PW et al (2003) Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 97:2530–2543CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  • M. Lehnhardt
    • 1
    Email author
  • A. Sogorski
    • 1
  • C. Wallner
    • 1
  • M. Wagner
    • 1
  • M. Dadras
    • 1
  • B. Behr
    • 1
  • K Harati
    • 1
  1. 1.Klinik für Plastische Chirurgie und Schwerbrandverletzte, Handchirurgiezentrum, Referenzzentrum für GliedmaßentumorenBG-Universitätskliniken Bergmannsheil Bochum, Ruhr-Universität-BochumBochumDeutschland

Personalised recommendations